Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Motor Neuron Disease, Amyotrophic Lateral Sclerosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)UnknownNCT03296501
What this trial is testing

Intraspinal Transplantation of Autologous ADRC in ALS Patients

Who this might be right for
Amyotrophic Lateral Sclerosis
Mossakowski Medical Research Centre Polish Academy of Sciences 30
Large-scale testing (Phase 3)Not Yet RecruitingNCT07174492
What this trial is testing

Efficacy and Safety of Masitinib in Combination With SoC Versus Placebo in the Treatment of ALS Patients

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
AB Science 412
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06513546
What this trial is testing

Evaluate the Safety, Efficacy, and Pharmacodynamics of PLL001 in ALS Patients

Who this might be right for
Amyotrophic Lateral SclerosisALS
PLL TX AUSTRALIA PTY LTD 153
Not applicableStudy completedNCT00606918
What this trial is testing

Validation of a New Device to Measure Neuromuscular Disease Progression

Who this might be right for
Amyotrophic Lateral Sclerosis & Other Neuromuscular Disorders
Massachusetts General Hospital 120
Very early researchActive Not RecruitingNCT06454682
What this trial is testing

An IIT Clinical Study to Evaluate the Safety and Efficacy of a Single Intrathecal Injection of RJK002 in Patients With ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
RJK Biopharma Ltd 9
Early research (Phase 1)UnknownNCT03049046
What this trial is testing

CC100: Phase 1 Multiple-Dose Safety and Tolerability in Subjects With ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
Chemigen, LLC 21
Early research (Phase 1)Study completedNCT02655614
What this trial is testing

GDC-0134 to Determine Initial Safety, Tolerability, and Pharmacokinetic Parameters in Participants With Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
Genentech, Inc. 54
Testing effectiveness (Phase 2)UnknownNCT04950647
What this trial is testing

Efficacy and Safety of Nitrazine in the Treatment of ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
Peking University Third Hospital 150
Not applicableStudy completedNCT04947436
What this trial is testing

ALS and Airway Clearance (ALSAC) Therapy

Who this might be right for
Amyotrophic Lateral SclerosisRespiratory Muscle Weakness
The University of Texas Health Science Center at San Antonio 28
Not applicableStudy completedNCT03489200
What this trial is testing

EH301 for the Treatment of ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
Elysium Health 32
Not applicableLooking for participantsNCT06528964
What this trial is testing

Proteinopathies Expression in Skin of Neurodegenerative Disorders

Who this might be right for
Alzheimer DiseaseFrontotemporal DementiaParkinson Disease+3 more
Universidad Autonoma de San Luis Potosí 40
Testing effectiveness (Phase 2)Study completedNCT00070993
What this trial is testing

Creatine for the Treatment of Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
National Center for Complementary and Integrative Health (NCCIH) 110
Not applicableLooking for participantsNCT07502677
What this trial is testing

Diagnostic Accuracy of SleepImage Technology for Detecting Respiratory Failure in Patients With Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
Royal Brompton & Harefield NHS Foundation Trust 15
Not applicableStudy completedNCT06325865
What this trial is testing

Perception of Unpleasant Sensations During Study Procedures in ALS Patients

Who this might be right for
Amyotrophic Lateral Sclerosis
Istituto Auxologico Italiano 15
Testing effectiveness (Phase 2)WithdrawnNCT03457753
What this trial is testing

Riluzole Oral Soluble Film Safety and Tolerability in Amyotrophic Lateral Sclerosis

Who this might be right for
ALS
Aquestive Therapeutics
Testing effectiveness (Phase 2)Study completedNCT03019419
What this trial is testing

Perampanel for Sporadic Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
ALS
Tokyo Medical University 66
Not applicableLooking for participantsNCT07413718
What this trial is testing

Inspiratory Muscle Training in Amiotrophyc Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Slerosis
University Ramon Llull 44
Not applicableStudy completedNCT04875949
What this trial is testing

Anti-Cholinergic Receptors Antibodies, Autonomic Profile and Dysautonomia Symptoms in PAF, ALS and POTS (DISAUT-AB)

Who this might be right for
Pure Autonomic FailureAmyotrophic Lateral SclerosisPostural Orthostatic Tachycardia Syndrome+1 more
Istituto Clinico Humanitas 75
Not applicableStudy completedNCT04446325
What this trial is testing

Venous Disease Thromboembolic and Amyotrophic Lateral Sclerosis

Who this might be right for
Lateral Amyotrophic SclerosisVenous Thrombo-embolic Desease
University Hospital, Brest 227
Testing effectiveness (Phase 2)Study completedNCT04165850
What this trial is testing

Open Label Study to Evaluate Ciprofloxacin/Celecoxib Combination in Patients With ALS

Who this might be right for
Amyotrophic Lateral SclerosisALS
NeuroSense Therapeutics Ltd. 16
Next Page